ArticleAtherosclerosis2014

CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism.

Bin Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.